Literature DB >> 18592774

[Metachronic testicular metastasis secondary to clear cell renal adenocarcinoma].

Roberto Llarena Ibarguren1, Jorge García-Olaverri Rodríguez, Igor Azurmendi Arin, Ivan Olano Grasa, Carlos Pertusa Peña.   

Abstract

OBJECTIVE: To report one case of unusual testicular metastasis from a renal origin.
METHODS: 57 year-old patient with disseminated right renal cancer under treatment who presented bone metastasis and a painful nodule in the upper pole of the right testicle during his follow-up with medical therapy, making surgery necessary. The pathology result was clear cell adenocarcinoma.
RESULTS: Six months later the patient continues under oral Sorafenib without evidence of new metastatic implants.
CONCLUSIONS: Testicular secondary metastatic tumors account for less than 1% of old testicular tumors. In patients in the fifth and sixth decades, mainly if they are affected by other neoplasias, testicular masses use to be metastatic implants. The most frequent origin is prostate.

Entities:  

Mesh:

Year:  2008        PMID: 18592774     DOI: 10.4321/s0004-06142008000400012

Source DB:  PubMed          Journal:  Arch Esp Urol        ISSN: 0004-0614            Impact factor:   0.436


  3 in total

Review 1.  Metachronous contralateral testicular and bilateral adrenal metastasis of chromophobe renal cell carcinoma: a case report and review of the literature.

Authors:  Hai-Yang Wu; Li-Wei Xu; You-Yun Zhang; Yan-Lan Yu; Xin-de Li; Gong-Hui Li
Journal:  J Zhejiang Univ Sci B       Date:  2010-05       Impact factor: 3.066

2.  Atypical presentations and rare metastatic sites of renal cell carcinoma: a review of case reports.

Authors:  Petros Sountoulides; Linda Metaxa; Luca Cindolo
Journal:  J Med Case Rep       Date:  2011-09-02

3.  Ultrasonographic features of testicular metastasis from renal clear cell carcinoma that mimics a seminoma: A case report.

Authors:  He Huang; Wenwu Ling; Tingting Qiu; Yan Luo
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.